Skip to main content
Top
Published in: BMC Pediatrics 1/2020

01-12-2020 | Vasculitis | Case report

Gastrointestinal hemorrhage before anticoagulant therapy in Kawasaki disease: a case report

Authors: Chenmin Hu, Yanping Yu

Published in: BMC Pediatrics | Issue 1/2020

Login to get access

Abstract

Background

Kawasaki disease (KD) is an acute febrile multisystem vasculitis and has been recognized to be the most common cause of acquired heart disease in children. Owing to its propensity to involve vessels throughout the entire body, KD often mimics other disease processes. The diagnosis might be delayed if other prominent symptoms appear before the characteristic clinical features of KD. Although gastrointestinal symptoms including vomiting, diarrhea, and abdominal pain are not uncommon in KD patients, KD with gastrointestinal bleeding is quite rare.

Case presentation

A previously healthy 4-year-old boy initially presented with abdominal pain, followed by fever, rash, and gastrointestinal hemorrhage, eventually diagnosed as complete KD. The patient recovered smoothly after appropriate management and no subsequent complications occurred in the following months.

Conclusion

The diagnosis of KD should be considered in children presenting with abdominal symptoms and fever without definable cause. Pediatricians should be aware of the risk of gastrointestinal bleeding in patients with KD, especially in those with prominent abdominal symptoms.
Literature
1.
go back to reference McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term Management of Kawasaki Disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927–99.CrossRef McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term Management of Kawasaki Disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927–99.CrossRef
2.
go back to reference Colomba C, La Placa S, Saporito L, et al. Intestinal Involvement in Kawasaki Disease. J Pediatr. 2018;202:186–93.CrossRef Colomba C, La Placa S, Saporito L, et al. Intestinal Involvement in Kawasaki Disease. J Pediatr. 2018;202:186–93.CrossRef
3.
go back to reference Singh S, Vignesh P, Burgner D. The epidemiology of Kawasaki disease: a global update. Arch Dis Child. 2015;100(11):1084–8.CrossRef Singh S, Vignesh P, Burgner D. The epidemiology of Kawasaki disease: a global update. Arch Dis Child. 2015;100(11):1084–8.CrossRef
4.
go back to reference Singh S, Jindal AK, Pilania RK. Diagnosis of Kawasaki disease. Int J Rheum Dis. 2018;21:36–44.CrossRef Singh S, Jindal AK, Pilania RK. Diagnosis of Kawasaki disease. Int J Rheum Dis. 2018;21:36–44.CrossRef
5.
go back to reference Marchesi A, Tarissi de Jacobis I, Rigante D, et al. Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase. Ital J Pediatr. 2018;44(1):102.CrossRef Marchesi A, Tarissi de Jacobis I, Rigante D, et al. Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase. Ital J Pediatr. 2018;44(1):102.CrossRef
6.
go back to reference Zulian F, Falcini F, Zancan L, et al. Acute surgical abdomen as presenting manifestation of Kawasaki disease. J Pediatr. 2003;142:731–5.CrossRef Zulian F, Falcini F, Zancan L, et al. Acute surgical abdomen as presenting manifestation of Kawasaki disease. J Pediatr. 2003;142:731–5.CrossRef
7.
go back to reference Fabi M, Corinaldesi E, Pierantoni L, et al. Gastrointestinal presentation of Kawasaki disease: a red flag for severe disease? PLoS One. 2018;13(9):e0202658.CrossRef Fabi M, Corinaldesi E, Pierantoni L, et al. Gastrointestinal presentation of Kawasaki disease: a red flag for severe disease? PLoS One. 2018;13(9):e0202658.CrossRef
8.
go back to reference Principi N, Rigante D, Esposito S. The role of infection in Kawasaki syndrome. J Inf Secur. 2013;67(1):1–10. Principi N, Rigante D, Esposito S. The role of infection in Kawasaki syndrome. J Inf Secur. 2013;67(1):1–10.
9.
go back to reference Nakamura A, Ikeda K, Hamaoka K. Aetiological significance of infectious stimuli in Kawasaki disease. Front Pediatr. 2019;7:244.CrossRef Nakamura A, Ikeda K, Hamaoka K. Aetiological significance of infectious stimuli in Kawasaki disease. Front Pediatr. 2019;7:244.CrossRef
10.
go back to reference Esposito S, Polinori I, Rigante D. The gut microbiota-host partnership as a potential driver of Kawasaki syndrome. Front Pediatr. 2019;7:124.CrossRef Esposito S, Polinori I, Rigante D. The gut microbiota-host partnership as a potential driver of Kawasaki syndrome. Front Pediatr. 2019;7:124.CrossRef
11.
go back to reference Matsubara T, Mason W, Kashani IA, Kligerman M, Burns JC. Gastrointestinal hemorrhage complicating aspirin therapy in acute Kawasaki disease. J Pediatr. 1996;128:701–3.CrossRef Matsubara T, Mason W, Kashani IA, Kligerman M, Burns JC. Gastrointestinal hemorrhage complicating aspirin therapy in acute Kawasaki disease. J Pediatr. 1996;128:701–3.CrossRef
12.
go back to reference Singh R, Ward C, Walton M, et al. Atypical Kawasaki disease and gastrointestinal manifestations. Paediatr Child Health. 2007;12:235–7.CrossRef Singh R, Ward C, Walton M, et al. Atypical Kawasaki disease and gastrointestinal manifestations. Paediatr Child Health. 2007;12:235–7.CrossRef
13.
go back to reference Chang CH, Chen MH, Yang W. Kawasaki disease presenting with lymphadenopathy and gastrointestinal hemorrhage: report of one case. Acta Paediatr Taiwan. 2004;45:171–3.PubMed Chang CH, Chen MH, Yang W. Kawasaki disease presenting with lymphadenopathy and gastrointestinal hemorrhage: report of one case. Acta Paediatr Taiwan. 2004;45:171–3.PubMed
14.
go back to reference Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes inKawasaki Disease. PLoS One. 2015;10:e0144603.CrossRef Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes inKawasaki Disease. PLoS One. 2015;10:e0144603.CrossRef
15.
go back to reference Zheng X, Yue P, Liu L, et al. Efficacy between low and high dose aspirin for the initial treatment of Kawasaki disease: Current evidence based on a meta-analysis. PLoS One. 2019;14:e0217274.CrossRef Zheng X, Yue P, Liu L, et al. Efficacy between low and high dose aspirin for the initial treatment of Kawasaki disease: Current evidence based on a meta-analysis. PLoS One. 2019;14:e0217274.CrossRef
Metadata
Title
Gastrointestinal hemorrhage before anticoagulant therapy in Kawasaki disease: a case report
Authors
Chenmin Hu
Yanping Yu
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2020
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-020-1916-6

Other articles of this Issue 1/2020

BMC Pediatrics 1/2020 Go to the issue